CE-MRA | TTE | Bias (LoA) | Bias% | Pearson r | ICC (95% CI) | |
---|---|---|---|---|---|---|
All patients n = 65 | ||||||
LA volume, ml (±SD) | 106 ± 44 | 78 ± 26 | 28 (− 22–77) | 30% | 0.85a | 0.86 (0.77–0.91)a |
LA volume index, ml/m2 (±SD) | 51 ± 22 | 37 ± 13 | 14 (− 12–39) | 32% | 0.87a | 0.86 (0.77–0.91)a |
Sinus Rhythm n = 14 | ||||||
LA volume, ml (±SD) | 88 ± 24 | 67 ± 16 | 21 (−22–64) | 27% | 0.45 | 0.59 (−0.27–0.87) |
LA volume index, ml/m2 (±SD) | 45 ± 15 | 34 ± 9 | 11 (−13–35) | 28% | 0.57a | 0.66 (− 0.05–0.89)a |
Atrial Fibrillation n = 11 | ||||||
LA volume, ml (±SD) | 125 ± 28 | 85 ± 23 | 39 (13–65) | 37% | 0.88a | 0.93 (0.74–0.98)a |
LA volume index, ml/m2 (±SD) | 58 ± 13 | 39 ± 9 | 19 (4–33) | 38% | 0.82a | 0.87 (0.52–0.97)a |
Discordant or unknown rhythm during CE-MRA n = 40 | ||||||
LA volume, ml (±SD) | 107 ± 50 | 80 ± 29 | 27 (−28–82) | 29% | 0.88a | 0.87 (0.75–0.93)a |
LA volume index, ml/m2 (±SD) | 51 ± 26 | 38 ± 15 | 13 (−15–41) | 29% | 0.90a | 0.88 (0.77–0.93)a |